Zhaoke Ophthalmology Limited (6622.HK)

HKD 1.32

(0.0%)

Long Term Debt Summary of Zhaoke Ophthalmology Limited

Zhaoke Ophthalmology Limited's latest annual long term debt in 2023 was 21.86 Million CNY , down -21.08% from previous year.
Zhaoke Ophthalmology Limited's latest quarterly long term debt in 2024 Q2 was - CNY , down 0.0% from previous quarter.
Zhaoke Ophthalmology Limited reported annual long term debt of 27.7 Million CNY in 2022, up 32.8% from previous year.
Zhaoke Ophthalmology Limited reported annual long term debt of 20.86 Million CNY in 2021, down -8.42% from previous year.
Zhaoke Ophthalmology Limited reported quarterly long term debt of - CNY for 2024 Q1, down 0.0% from previous quarter.
Zhaoke Ophthalmology Limited reported quarterly long term debt of 21.86 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Zhaoke Ophthalmology Limited (2023 - 2018)

Historical Annual Long Term Debt of Zhaoke Ophthalmology Limited (2023 - 2018)

Year	Long Term Debt	Long Term Debt Growth
2023	21.86 Million CNY	-21.08%
2022	27.7 Million CNY	32.8%
2021	20.86 Million CNY	-8.42%
2020	22.77 Million CNY	-12.69%
2019	26.08 Million CNY	15.05%
2018	22.67 Million CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- CNY	0.0%
2024 Q1	- CNY	0.0%
2023 Q4	21.86 Million CNY	0.0%
2023 FY	21.86 Million CNY	-21.08%
2023 Q3	21.86 Million CNY	-17.15%
2023 Q2	26.39 Million CNY	0.0%
2023 Q1	26.39 Million CNY	-4.74%
2022 Q4	27.7 Million CNY	0.0%
2022 Q1	29.28 Million CNY	40.39%
2022 Q2	29.28 Million CNY	0.0%
2022 FY	27.7 Million CNY	32.8%
2022 Q3	27.7 Million CNY	-5.41%
2021 Q1	24.78 Million CNY	8.8%
2021 FY	20.86 Million CNY	-8.42%
2021 Q2	24.78 Million CNY	0.0%
2021 Q4	20.86 Million CNY	0.0%
2021 Q3	20.86 Million CNY	-15.83%
2020 FY	22.77 Million CNY	-12.69%
2020 Q4	22.77 Million CNY	0.0%
2020 Q1	- CNY	-100.0%
2019 Q4	395.77 Million CNY	0.0%
2019 FY	26.08 Million CNY	15.05%
2018 FY	22.67 Million CNY	0.0%

Peer Long Term Debt Comparison of Zhaoke Ophthalmology Limited

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	28.577%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	99.488%